Giulia D'Urso, Alessandra E. Thomann, J. Anzures‐Cabrera, B. Zinnhardt, Benedicte Ricci, L. Bailey, Krzysztof Śmigórski, V. Machado, Eva Zsuszsanna Mracskó, N. Pavese, K. Marek, K. Brockmann, T. Simuni, Nicoletta Milani Muelhardt, G. Pagano
{"title":"Ib期研究设计评估Selnoflast的安全性、药代动力学和药效学,Selnoflast是一种新型NLRP3炎性体抑制剂,用于早期PD (P2-11.007)","authors":"Giulia D'Urso, Alessandra E. Thomann, J. Anzures‐Cabrera, B. Zinnhardt, Benedicte Ricci, L. Bailey, Krzysztof Śmigórski, V. Machado, Eva Zsuszsanna Mracskó, N. Pavese, K. Marek, K. Brockmann, T. Simuni, Nicoletta Milani Muelhardt, G. Pagano","doi":"10.1212/wnl.0000000000203618","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":334567,"journal":{"name":"Sunday, April 23","volume":"8 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Phase Ib Study Design Evaluating The Safety, Pharmacokinetics And Pharmacodynamics Of Selnoflast, A Novel NLRP3 Inflammasome Inhibitor In Early-Stage PD (P2-11.007)\",\"authors\":\"Giulia D'Urso, Alessandra E. Thomann, J. Anzures‐Cabrera, B. Zinnhardt, Benedicte Ricci, L. Bailey, Krzysztof Śmigórski, V. Machado, Eva Zsuszsanna Mracskó, N. Pavese, K. Marek, K. Brockmann, T. Simuni, Nicoletta Milani Muelhardt, G. Pagano\",\"doi\":\"10.1212/wnl.0000000000203618\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":334567,\"journal\":{\"name\":\"Sunday, April 23\",\"volume\":\"8 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-04-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Sunday, April 23\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1212/wnl.0000000000203618\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sunday, April 23","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1212/wnl.0000000000203618","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Phase Ib Study Design Evaluating The Safety, Pharmacokinetics And Pharmacodynamics Of Selnoflast, A Novel NLRP3 Inflammasome Inhibitor In Early-Stage PD (P2-11.007)